Results 11 to 20 of about 64,042 (297)

Anaphylaxis [PDF]

open access: yesThe Journal of Emergency Medicine, 2014
Anaphylaxis is the quintessential critical illness in emergency medicine. Symptoms are rapid in onset and death can occur within minutes. Approximately 1500 patients die annually in the United States from this deadly disorder. It is imperative, therefore, that emergency care providers be able to diagnose and appropriately treat patients with ...
Jeffrey, Zilberstein   +2 more
core   +6 more sources

Anaphylaxis [PDF]

open access: yesEuropean Annals of Allergy and Clinical Immunology, 2020
Anaphylaxis is the most severe systemic hypersensitivity reaction, and it can be life-threatening or even fatal. It involves the activation of multiple immune and non immune pathways beyond IgE, thus exhibiting different phenotypes. New symptoms of hypersensitivity caused by chemotherapy drugs, monoclonal antibodies, and biological agents have been ...
M B, Bilò   +4 more
openaire   +3 more sources

Anaphylaxis

open access: yesMedicina Clínica (English Edition)
Abstract Anaphylaxis is an acute, potentially fatal systemic hypersensitivity reaction with varied mechanisms and clinical presentations. Although prompt recognition and treatment of anaphylaxis are imperative, both patients and healthcare professionals often fail to recognize and diagnose its early signs. Clinical manifestations vary widely,
Victoria, Cardona   +2 more
core   +9 more sources

Anaphylaxis [PDF]

open access: yesAllergy, Asthma & Clinical Immunology, 2011
Anaphylaxis is an acute, potentially fatal systemic reaction with varied mechanisms and clinical presentations. Although prompt recognition and treatment of anaphylaxis are imperative, both patients and healthcare professionals often fail to recognize and diagnose early signs and symptoms of the condition.
Kim, Harold, Fischer, David
openaire   +6 more sources

Refractory Anaphylaxis: Data From the European Anaphylaxis Registry [PDF]

open access: yesFrontiers in Immunology, 2019
Refractory anaphylaxis (unresponsive to treatment with at least two doses of minimum 300 μg adrenaline) is a rare and often fatal hypersensitivity reaction. Comprehensive data on its definition, prevalence, and risk factors are missing.
Wojciech Francuzik   +9 more
doaj   +2 more sources

Anaphylaxis [PDF]

open access: yesChest, 2018
Anaphylaxis is a systemic, life-threatening disorder triggered by mediators released by mast cells and basophils activated via allergic (IgE-mediated) or nonallergic (non-IgE-mediated) mechanisms. It is a rapidly evolving, multisystem process involving the integumentary, pulmonary, gastrointestinal, and cardiovascular systems.
Daniel, LoVerde   +3 more
openaire   +6 more sources

Beyond the Usual: Pantoprazole-Induced Anaphylaxis During Peribulbar Anesthesia [PDF]

open access: yes, 2023
Proton-pump inhibitors (PPIs) are one of the most prescribed drugs in the world. Although they are remarkably safe, with minimal adverse effects, it has rarely been reported as a cause of anaphylaxis.
Mateus, Carolina   +7 more
core   +1 more source

RISK FACTORS FOR SEVERE PEDIATRIC FOOD ANAPHYLAXIS IN ITALY.

open access: yes, 2011
Background: Little is known about the cause of food-induced anaphylaxis in children or about the factors that might affect its clinical severity. Objective: The aim of this study was to investigate the cause of food-induced anaphylaxis in children in ...
Martelli A.   +11 more
core   +3 more sources

Implementation of anaphylaxis management guidelines [PDF]

open access: yes, 2012
Anaphylaxis management guidelines recommend the use of intramuscular adrenaline in severe reactions, complemented by antihistamines and corticoids; secondary prevention includes allergen avoidance and provision of self-applicable first aid drugs.
Koehli, Alice   +12 more
core   +1 more source

Peptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis [PDF]

open access: yes, 2007
Administration of peptide antigens in tolerogenic form holds promise as a specific treatment for autoimmune and allergic disorders. However, experiments in rodent autoimmune models have highlighted the risk of anaphylaxis in response to systemic peptide ...
Stephen M. Anderton   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy